Last updated: September 21, 2023
Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Overall Status: Active - Recruiting
Phase
N/A
Condition
Reflex Sympathetic Dystrophy Syndrome (Rsds)
Arthritis And Arthritic Pain
Muscle Pain
Treatment
I-One
Clinical Study ID
NCT05922618
PeCFoA
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of type I CRPS according to the Budapest criteria (table 1)
- Type I CRPS involving the ankle or foot
- Onset of CRPS type I up to a maximum of 3 years after the symptomatic event
- Pain on visual analog scale (VAS) scale quantified as intensity at least ≥ 5 atrecruitment
- Pharmacological treatment with first infusion cycle of neridronate
Exclusion
Exclusion Criteria:
- Neurological pathologies (stroke, degenerative, traumatic pathologies)
- Local neurological impairment (type II CRPS), confirmed by a conduction test orsimilar
- Cardiac pacemaker, treatment site malignancy
Study Design
Total Participants: 28
Treatment Group(s): 1
Primary Treatment: I-One
Phase:
Study Start date:
August 01, 2023
Estimated Completion Date:
June 01, 2027
Study Description
Connect with a study center
Angela Notarnicola
Bari, 70124
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.